CD276 and neoplasm: In conclusion, our research establishes that hsa-miR-214-3p can modulate the expression of B7H3 in breast cancer cells, thereby inhibiting tumor cell proliferation, reinvigorating immune cell activity, and ameliorating the immune microenvironment.